Skip to main content

Table 6 Percentage change in HIV-test intervalsa (min, maxb) in mixing scenarios compared to no-mixing (EHE plan)

From: Evaluating the sensitivity of jurisdictional heterogeneity and jurisdictional mixing in national level HIV prevention analyses: context of the U.S. ending the HIV epidemic plan

Year ➔

Mid intervention year

(2022 for EHE and 2028 for non-EHE) d

Target year

(2025 for EHE and 2030 for non-EHE) d

Scenario no. ➔

S13

S14

S15

S16

S13

S14

S15

S16

Mixing assumption ➔

No-mixing

Mixing level 1

Mixing level 2

Mixing level 3

No-mixing

Mixing level 1

Mixing level 2

Mixing level 3

Risk group

Jurisdicton type

Test interval

MSM

EHE

<  2 years

Ref

−14, 9%

−32, 25%

− 35, 20%

Ref

−23, 5%

−44, 13%

− 45, 12%

2–4 years

Ref

−9, 10%

− 23, 36%

− 20, 34%

Ref

2, 10%

4, 34%

6, 30%

Non-EHE

<  2 years

Ref

−2, 15%

0, 53%

−16, 48%

Ref

− 4, 13%

− 7, 50%

− 14, 37%

2–4 years

Ref

10, 15%

34, 60%

36, 37%

Ref

*

*

*

HF

EHE

<  2 years

Ref

−12, 6%

−29, 19%

− 28, 21%

Ref

− 21, 4%

− 43, 11%

− 40, 13%

2–4 years

Ref

−9, 9%

− 23, 35%

− 22, 28%

Ref

−14, 8%

− 33, 28%

− 28, 28%

Non-EHE

<  2 years

Ref

−3, 11%

− 3, 39%

−15, 36%

Ref

− 5, 9%

− 11, 30%

− 14, 26%

2–4 years

Ref

− 5, 6%

−8, 19%

− 14, 18%

Ref

−7, 4%

− 15, 12%

− 14, 12%

HM

EHE

<  2 years

Ref

−8, 5%

− 25, 22%

−26, 20%

Ref

− 11, 6%

− 27, 31%

− 29, 32%

2–4 years

Ref

− 9, 8%

− 29, 36%

−25, 36%

Ref

− 5, 7%

− 19, 30%

− 15, 33%

Non-EHE

<  2 years

Ref

−3, 11%

− 7, 41%

−17, 30%

Ref

−12, 10%

− 28, 32%

− 26, 23%

2–4 years

Ref

− 13, 7%

− 28, 24%

− 27, 27%

Ref

*

*

*

All

National

<  2 years

Ref

− 14, 15%

− 32, 53%

− 45, 48%

Ref

− 23, 13%

− 44, 50%

− 45, 37%

2–4 years

−13,15%

− 29, 60%

− 27, 37%

−14, 10%

− 33, 34%

−28, 37%

  1. HM Heterosexual males, HF Heterosexual females, MSM Men who have sex with men
  2. National: aggregate of all EHE and non-EHE jurisdictions; EHE: aggregate of all EHE jurisdictions; Non-EHE: aggregate of all non-EHE jurisdictions;
  3. a % change in HIV-testing interval estimate in mixing scenarios compared to no-mixing scenario and calculated as 100 × (mixing scenario – no-mixing scenario)/mixing scenario)
  4. b Values presented are the range (minimum, maximum) across the jurisdiction type for the specific time interval cohort (i.e., < 2 years (minimum value was 6 months) or 2–4 years)
  5. c Scenarios 13 to 16 scale-up care metrics (HIV-diagnosis rate, care-drop-out rate, and PrEP coverage) to reach EHE targets by 2025 for EHE jurisdictions and by 2030 for non-EHE jurisdictions
  6. d Results presented for mid-intervention years (2022 for EHE and 2028 for non-EHE) and target year (2025 for EHE and 2030 for non-EHE)
  7. * No instances/scenarios were found where interval was 2–4 years
Back to article page

BMC Medical Research Methodology

ISSN: 1471-2288

Contact us